Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.
Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.
- India, Malaysia Explore Stronger Ties in Semiconductors & Manufacturing
- Tencent Reports Strongest Growth in a Year, Driven by Hit Games
- iHub Robotics Secures Rs 4.3 Crore in Pre-Seed Funding Round
- Pentagon plans to cut up to 60,000 civilian jobs
- West Bengal Govt Announces Rs 6,800 Bonus for Employees, Rs 3,500 for Pensioners
“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.
